Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications
MSMarisol S. CastanetoDADavid A. GorelickNANathalie A. DesrosiersRLRebecca L. HartmanSPSandrine Pirard
University of Maryland, Baltimore · National Institute on Drug Abuse
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
697
total citations
- FWCI
- 57.53
- Percentile
- 100%
- References
- 221
Citations per year
Authors
6- MSMarisol S. Castaneto
University of Maryland, Baltimore, National Institute on Drug Abuse
- DADavid A. Gorelick
University of Maryland, Baltimore
- NANathalie A. Desrosiers
University of Maryland, Baltimore, National Institute on Drug Abuse
- RLRebecca L. Hartman
University of Maryland, Baltimore, National Institute on Drug Abuse
- SPSandrine Pirard
National Institute on Drug Abuse
Topics & keywords
Topics
Keywords
- Synthetic cannabinoids
- Medicine
- Cannabis
- Cannabinoid receptor
- Cannabinoid
- Hallucinogen
- Pharmacology
- Delta-9-tetrahydrocannabinol
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.